Sympatient develops digital anxiety therapy.
Sympatient has raised €9.1M across 2 funding rounds from 2 investors, most recently a Series A round in Sep 2022. Based in Hamburg, Germany; founded 2017; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2022-09-29 | Series A | €7.5M | Verve Ventures | View deal → |
| 2020-05-28 | Seed | €1.6M | Investiere | View deal → |
